Regulatory StrategyREG-006Publishedv1.0.0

Post-Approval Commitment Tracker Pack

Never miss a post-approval obligation deadline

~20s runtime3 evidence sources3 regulatory mappingsUpdated Dec 2025

Summary

Tracks and manages post-marketing requirements, commitments, and REMS obligations with precedent-based timelines and compliance monitoring.

Detailed Description

The Post-Approval Commitment Tracker Pack provides comprehensive management of post-marketing requirements (PMRs), post-marketing commitments (PMCs), and REMS obligations following FDA approval. It draws on the FDA PMR/PMC database, REMS catalog, and regulatory compliance precedents to help sponsors maintain compliance and avoid enforcement actions.

The pack catalogs all post-approval obligations for your product and benchmarks them against fulfillment timelines and outcomes from analogous products. It identifies obligations at risk of delay, provides early warning of potential compliance issues, and maps the regulatory consequences of missed deadlines.

Deliverables include a comprehensive obligation tracker dashboard, a risk-prioritized compliance timeline, and a benchmarking analysis of post-approval commitment fulfillment rates and timelines across comparable approved products.

Evidence Sources

SourceTypeDescriptionRefresh
FDA PMR/PMC DatabaseREGULATORYFDA database of post-marketing requirements and commitments with status and timelinesMonthly
REMS Obligation CatalogREGULATORYComplete catalog of REMS programs with element requirements, assessment timelines, and modification historyMonthly
Compliance Precedent DatabaseCURATEDHistorical analysis of PMR/PMC fulfillment rates, timeline patterns, and enforcement actionsQuarterly

Regulatory Mapping

FDA21 CFR 314.81

Post-Marketing Reporting Requirements

PRIMARY
FDASection 505(o)(3) FD&C Act

Post-Marketing Studies and Clinical Trials

PRIMARY
FDAFDA-2019-D-5019

REMS: Modifications and Revisions Guidance

SECONDARY

Agent Transparency

When you run this pack, your request is processed by a pipeline of specialized AI agents. Each agent operates with a defined confidence threshold and is auditable end-to-end.

🔍

Evidence Retriever

brew-retriever-v3

Step 1

Queries curated sources for relevant evidence objects. Searches across regulatory databases, clinical registries, and scientific literature to surface the most pertinent references for the pack domain.

Confidence floor: 85%Avg latency: 4-8s
🧬

Domain Analyzer

brew-domain-analyst-v2

Step 2

Applies domain-specific reasoning and regulatory mapping. Interprets evidence in the context of FDA, ICH, and EMA frameworks and tags each finding with the relevant guidance references.

Confidence floor: 80%Avg latency: 6-12s
📊

Evidence Synthesizer

brew-synthesizer-v2

Step 3

Synthesizes findings into structured output. Combines retrieved evidence and domain analysis into a cohesive narrative with quantitative summaries, comparative tables, and actionable recommendations.

Confidence floor: 82%Avg latency: 8-15s

Output Validator

brew-validator-v1

Step 4

Validates citations, checks confidence thresholds, and ensures all referenced sources are accessible and correctly attributed. Flags any claims that fall below the confidence floor.

Confidence floor: 90%Avg latency: 2-4s

Sample Outputs

Obligation Tracker Dashboard

HTML

Comprehensive dashboard tracking all post-approval obligations with status, deadlines, and risk indicators

Risk-Prioritized Compliance Timeline

PDF

Timeline visualization of all obligations with risk scoring and early warning indicators

Fulfillment Benchmarking Analysis

XLSX

Comparative analysis of PMR/PMC fulfillment timelines and outcomes across comparable products

Deliverables included

  • Post-approval obligation tracker dashboard
  • Risk-prioritized compliance timeline
  • PMR/PMC fulfillment benchmarking analysis
  • REMS compliance monitoring plan
  • Annual reporting preparation checklist

Related Disease & Biomarker Mappings

Therapeutic AreaDisease FamilyKey BiomarkersRelevance
Cross-TherapeuticRegulatory Strategy
N/A — regulatory focus
Primary
OncologyAccelerated Approval Programs
ORRDORctDNA response
Secondary

Related Packs in Regulatory Strategy

Version History

v1.0.0CurrentNovember 14, 2025

Current release — expanded evidence sources, improved citation accuracy, and added new regulatory cross-references.

v0.9.0October 15, 2025

Beta release — validated with domain SMEs. Added sample output previews and refined confidence scoring.

v0.1.0September 15, 2025

Initial draft — core evidence retrieval pipeline and output schema established.

Need a Custom Evidence Pack?

Our enterprise team can build bespoke evidence packs tailored to your therapeutic area, regulatory strategy, or internal decision framework. Custom packs include dedicated evidence source curation, domain-specific agent tuning, and priority SLA support.

Enterprise packs are available for organizations on the BrewBio Pro or Enterprise plan.